PPAR Gamma Receptor: A Novel Target to Improve Morbidity in Preterm Babies.

Pharmaceuticals (Basel) · 2023 · PMC10675178 · PMID 38004396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The distance travelled and speed within both the entire and central arena showed a trend toward an increase in rosiglitazone-treated kits compared with vehicle controls; however, this comparison was not statistically significant. 2.3.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.